Role of the CHDH/p-CREB Axis in Regulating Breast Cancer Pathogenesis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500114631

Enrollment

Unknown

Registered

2025-12-16

Start date

2026-01-01

Completion date

Unknown

Last updated

2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Observation group:None

Eligibility

Sex/Gender

Female

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Pathologically confirmed breast cancer; 2.Aged 18 to 70 years; 3.Voluntarily signed informed consent form; 4.Complete clinical data;

Exclusion criteria

Exclusion criteria: 1.History of other malignant tumors; 2.Severe organ dysfunction; 3.Pregnancy or lactation; 4.Inability to be followed up;

Design outcomes

Primary

Measure	Time frame
CHDH;Overall survival;Disease-free survival period;	—

Countries

China

Contacts

Public ContactYifei Li

Dalian Women and Children's Medical Group

m17673114728@163.com+86 411 66861926

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026